CIK 0001759425 · Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831281555
- Phone
- 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,138,950
- in 6 filings, $4.8M under 10b5-1 plans
Net −$11,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Brege Laura Director | Option exercise | +14,167 | $16.71 | $237K | 29,870 |
| 2026-11-11 | Brege Laura Director | Sale | −10,907 | $94.05 | $1.0M | 18,963 |
| 2026-11-11 | Brege Laura Director | Sale | −3,260 | $94.74 | $309K | 15,703 |
| 2026-11-11 | Brege Laura Director | Option exercise · Stock Option (right to buy) | −14,167 | 0 | ||
| 2026-11-04 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +20,000 | $2.94 | $59K | 226,637 |
| 2026-11-04 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −20,000 | $90.00 | $1.8M | 206,637 |
| 2026-11-04 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −20,000 | 38,487 | ||
| 2026-10-16 | Howe Jolanda SVP, GLOBAL CONTROLLER | Option exercise | +16,112 | $19.24 | $310K | 16,728 |
| 2026-10-16 | Howe Jolanda SVP, GLOBAL CONTROLLER | Option exercise · Employee Stock Option (right to buy) | −16,112 | 8,888 | ||
| 2026-10-09 | Myers Robert Paul Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-10-09 | Myers Robert Paul Chief Medical Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2026-10-06 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise | +5,305 | $19.19 | $102K | 199,745 |
| 2026-10-06 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise | +6,892 | $15.87 | $109K | 206,637 |
| 2026-10-06 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise · Employee Stock Option (right to buy) | −5,305 | 169,695 | ||
| 2026-10-06 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise · Employee Stock Option (right to buy) | −6,892 | 233,108 | ||
| 2026-09-14 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale | −9,943 | $98.37 | $978K | 44,745 |
| 2026-09-11 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Option exercise | +18,333 | 54,688 | ||
| 2026-09-11 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −18,333 | 0 | ||
| 2026-09-02 | Howe Jolanda SVP, GLOBAL CONTROLLER | Sale 10b5-1 | −658 | $100.00 | $66K | 616 |
| 2026-09-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +30,000 | $2.94 | $88K | 224,440 |
Page 1 of 15 · 294 trades